More Videos
|
CNBC'S MOST SHARED
- 'We're in the Middle of a Crash': Black Swan
- The Rising Mountain of Debt May Be the Next Crisis
- Latvian Banker Taking Souls as Collateral
- The Worst Expected 2010 State Budget Gaps
- Alaska Governor Sarah Palin Will Resign
- Cuddle Parties Heat Up
- SEC May Reinstate Rules for Short-Selling Stocks
- Malaysia PM Speaks to CNBC
- Your First Move For Monday July 6th
- NY City Apartment Sales Down More Than 50%
- Fireworks At Pharma's Market
- Value of Warren Buffett's Annual Gift to Gates Foundation Falls Along With Berkshire's Stock
- Michael Jackson: The Music And The Money
- Five Stock Picks for This Market
- Realities of the New Obama Refis
- Weak Dollar Means Gold at $1,040: Strategist
- Court Ruling Could Mean Trouble for TiVo
- Lance, Please Back Out Of Tour
- TeleMedicine Gets An Apple App Store Facelift
- The Rising Mountain of Debt May Be the Next Crisis
- Alaska Governor Sarah Palin Will Resign
- For Banks, Wads of Cash and Loads of Trouble
- SEC May Reinstate Rules for Short-Selling Stocks
- For Australian Winemakers, More Turns Out to Be Less
- Earnings Season: A Likely Game-Changer
- Slideshow: Best-Selling Fourth of July Fireworks
- Divisions Dominate as Third Quarter Begins
- Stanford Clients Sue Insurance Broker Willis Group
RSS FEED
Text Size 
Here are some of the video clips I've done today on ASCO (American Society of Clinical Oncology) conference in Chicago. It's the world's biggest cancer conference and Wall Street's most keenly-watched medical meeting.
The clips are in order, with most recent at the top.
Highlights of the conference.
A promising brain cancer vaccine that has shown new positive test results, with John Sampson, Duke University Medical Center.
A breakthrough for patients suffering from brain cancer.
Discussing breakthroughs in drug cancer drugs and a company outlook, with Sol Barer, Celgene CEO.
ImClone's Erbitrux lung cancer drug is grabbing the spotlight.
Researchers will unveil new clinical trial results on a promising treatment for brain cancer.
An outlook on Genentech from ASCO, with Dr. Susan Desmond-Hellmann, former oncologist.
Deatils on the conference.
Questions? Comments?
Data is a real-time snapshot *Data is delayed at least 15 minutes